The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation.
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The principal regulator of erythropoiesis is the glycoprotein erythropoietin, which interacts with a specific cell surface receptor (EpoR). A study aimed at analyzing EpoR gene regulation has shown that both pluripotent embryonal stem cells and early multipotent hematopoietic cells express EpoR transcripts. Commitment to nonerythroid lineages (e.g., macrophage or lymphocytic) results in the shutdown of EpoR gene expression, whereas commitment to the erythroid lineage is concurrent with or followed by dramatic increases in EpoR transcription. To determine whether gene activity could be correlated with chromatin alterations, DNase-hypersensitive sites (HSS) were mapped. Two major HSS located in the promoter region and within the first intron of the EpoR gene are present in all embryonal stem and hematopoietic cells tested, the intensities of which correlate well with EpoR expression levels. In addition, a third major HSS also located within the first intron of the EpoR gene is uniquely present in erythroid cells that express high levels of EpoR. Transfection assays show that sequences surrounding this major HSS impart erythroid cell-specific enhancer activity to a heterologous promoter and that this activity is at least in part mediated by GATA-1. These data, together with concordant expression levels of GATA-1 and EpoR in both early multipotent hematopoietic and committed erythroid cells, support a regulatory role of the erythroid cell-specific transcription factor GATA-1 in EpoR transcription in these cells. However, the lack of significant levels of GATA-1 expression in embryonal stem cells implies an alternative regulatory mechanism of EpoR transcription in cells not committed to the hematopoietic lineage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956
Metcalf, D. (1989) · Nature · doi:10.1038/339027a0 · Cited by 1,023
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
Moreau-Gachelin, F., Tavitian, A., & Tambourin, P. (1988) · Nature · doi:10.1038/331277a0 · Cited by 447
Ben-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403
Wall, L., deBoer, E., & Grosveld, F. (1988) · Genes & Development · doi:10.1101/gad.2.9.1089 · Cited by 350
Structure and promoter activity of the gene for the erythroid transcription factor GATA-1.
Hannon, R., Evans, T., Felsenfeld, G., & Gould, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3004 · Cited by 124
Cited by
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A., & Weissman, I. L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141007 · Cited by 997
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Hematopoietic commitment during embryonic stem cell differentiation in culture.
Keller, G., Kennedy, M., Papayannopoulou, T., & Wiles, M. V. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.473 · Cited by 881
Multilineage gene expression precedes commitment in the hemopoietic system.
Hu, M., Krause, D., Greaves, M., Sharkis, S., Dexter, M., Heyworth, C., & Enver, T. (1997) · Genes & Development · doi:10.1101/gad.11.6.774 · Cited by 729
The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development
Warren, A. J., Colledge, W. H., Carlton, M. B. L., Evans, M. J., Smith, A. J. H., & Rabbitts, T. H. (1994) · Cell · doi:10.1016/0092-8674(94)90571-1 · Cited by 606
Erythropoietin receptor mRNA expression in human endothelial cells.
Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E. S., Kessimian, N., & Noguchi, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3974 · Cited by 570
Localization of specific erythropoietin binding sites in defined areas of the mouse brain.
Digicaylioglu, M., Bichet, S., Marti, H. H., Wenger, R. H., Rivas, L. A., Bauer, C., & Gassmann, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3717 · Cited by 474
Lin, C. S., Lim, S. K., D'Agati, V, & Costantini, F. (1996) · Genes & Development · doi:10.1101/gad.10.2.154 · Cited by 423
Gregory, T., Yu, C., Ma, A., Orkin, S. H., Blobel, G. A., & Weiss, M. J. (1999) · Blood · doi:10.1182/blood.v94.1.87.413k41_87_96 · Cited by 366
Structure, function, and activation of the erythropoietin receptor
Youssoufian, H., Longmore, G., Neumann, D., Yoshimura, A., & Lodish, H. (1993) · Blood · doi:10.1182/blood.v81.9.2223.2223 · Cited by 355
Weiss, M. J., & Orkin, S. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9623 · Cited by 296
The molecular mechanism of erythropoietin action
KOURY, M. J., & BONDURANT, M. C. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17466.x · Cited by 265
Imada, K., Takaori-Kondo, A., Akagi, T., Shimotohno, K., Sugamura, K., Hattori, T., Yamabe, H., Okuma, M., & Uchiyama, T. (1995) · Blood · doi:10.1182/blood.v86.6.2350.bloodjournal8662350 · Cited by 60
Metadata
- Authors
- Heberlein, C., Fischer, K. D., Stoffel, M., Nowock, J., Ford, A., Tessmer, U., & Stocking, C.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1992-04
- Volume
- 12
- Issue
- 4
- Pages
- 1815-1826
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2112315202
- Cited by
- 80
- References
- 6
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.